Deruxtecan-Eribulin
Deruxtecan-Eribulin is a novel antibody-drug conjugate (ADC) linker-payload, combining the DNA topoisomerase I inhibitor Exatecan and the microtubule inhibitor Eribulin. This dual-mechanism conjugate is a key reagent for constructing ADCs used in cancer research, enabling the evaluation of targeted cytotoxicity in both in vitro and in vivo experimental models.
Product Specifications
Field of Research
Pharmacology & Drug Discovery
Molecular Formula
C120H148FN15O31
Molecular Weight
2315.54
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog